The UbiqVue 2A wearable biosensor allows doctors to monitor 12 patient health parameters remotely for up to five days. The device simplifies the monitoring of patients at home by reducing the number of monitoring devices required.

UltraGreen Cardiac Technologies has formed a strategic partnership with LifeSignals to distribute advanced cardiac monitoring biosensors worldwide, enhancing patient care.

LifeSignals, in collaboration with UltraLinQ, launches the UbiqVue 2AYe Holter System at Heart Rhythm 2025, transforming cardiac monitoring.

LifeSignals, Inc. celebrates the EU MDR Certification of its UbiqVue 2A Multiparameter System, enhancing patient monitoring capabilities across care environments.

LifeSignals has successfully obtained EU MDR Certification for its UbiqVue™ 2A Multiparameter System, enhancing patient monitoring capabilities in healthcare settings.

LifeSignals, Inc. announced the FDA 510(k) clearance for the UbiqVue 2A Multiparameter System, revolutionizing patient monitoring with advanced biosensor technology.

LifeSignals, Inc. has announced FDA clearance for its UbiqVue 2A, a cloud-based, multiparameter biosensor system designed for continuous patient monitoring and health management.

Single-use, 2-channel wearable Biosensor, patient-facing app and cloud-based system enable final Holter reports in hours—not days. MILPITAS, Calif., April 22, 2025 /PRNewswire/ -- LifeSignals, Inc. today announced the launch of the UbiqVue 2AYe Holter System at Heart Rhythm 2025 (Booth...

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient…